Title:
HETEROCYCLIC DERIVATIVE, AND COMPOSITION THEREOF AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/032600
Kind Code:
A1
Abstract:
Disclosed are a compound represented by general formula (I) or a stereoisomer, deuterated compound, solvate, prodrug, metabolite, pharmaceutically acceptable salt or eutectic crystal thereof, an intermediate thereof, and a use thereof in EGFR-related diseases such as cancer.
More Like This:
Inventors:
ZHANG CHEN (CN)
WANG JIANMIN (CN)
HUANG ZHENGGANG (CN)
TANG PINGMING (CN)
HUANG ANBANG (CN)
YU YAN (CN)
LI YAO (CN)
YAN PANGKE (CN)
WANG JIANMIN (CN)
HUANG ZHENGGANG (CN)
TANG PINGMING (CN)
HUANG ANBANG (CN)
YU YAN (CN)
LI YAO (CN)
YAN PANGKE (CN)
Application Number:
PCT/CN2023/111710
Publication Date:
February 15, 2024
Filing Date:
August 08, 2023
Export Citation:
Assignee:
TIBET HAISCO PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K31/506; C07D401/12; A61P35/00
Domestic Patent References:
WO2022194269A1 | 2022-09-22 | |||
WO2022228547A1 | 2022-11-03 | |||
WO2023278325A1 | 2023-01-05 | |||
WO2023066350A1 | 2023-04-27 | |||
WO2022055181A1 | 2022-03-17 |
Foreign References:
CN114286678A | 2022-04-05 | |||
CN109912655A | 2019-06-21 |
Attorney, Agent or Firm:
BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF:
Previous Patent: SESSION BINDING METHOD AND FUNCTION, AND STORAGE MEDIUM AND ELECTRONIC DEVICE
Next Patent: MULTI-LEVEL CONTROL SYSTEM FOR ROBOT
Next Patent: MULTI-LEVEL CONTROL SYSTEM FOR ROBOT